From Yahoo Finance: 2025-05-07 08:33:00

Billionaire Ray Dalio’s Bridgewater established in 1975, with Dalio no longer in key management but still active in investment and philanthropy. Despite Bridgewater’s growth, Dalio warned of potential risks to investors due to Trump’s tariff policies. Market corrections ensued, with the S&P 500 taking significant hits in April 2025, aligning with Dalio’s predictions.

President Trump’s tariffs, a cornerstone of his economic policy, led to market volatility and uncertainty, with the S&P 500 seeing a 12% pullback in early April 2025. Dalio expressed concerns about the long-term damage caused by the tariffs, warning of potential breakdowns in monetary and political orders.

While Dalio criticized Trump’s tariffs on NBC’s “Meet the Press,” the market reflected heightened fear and volatility, as shown by the CBOE Volatility Index (VIX) reaching a five-year high. Despite market turmoil, Bridgewater continued to thrive, posting a 9.9% growth in Q1 2025 amid difficult conditions.

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) emerged as one of Dalio’s Bridgewater’s stock picks with significant upside potential, ranking third on the list. The company reported record revenue in 2024, with strategic approvals for key treatments, positioning itself as a key player in the healthcare sector. Analysts highlighted the company’s growth prospects in the sleep disorder market.

Interested in hedge fund stock picks, we analyzed Bridgewater Associates’ holdings, focusing on stocks with at least 30% upside potential. Our research showed that imitating top hedge fund picks can outperform the market, with our newsletter strategy yielding significant returns since 2014. AI stocks were identified as having greater potential for higher returns in a shorter timeframe compared to traditional investments.



Read more at Yahoo Finance: Among Billionaire Ray Dalio’s Bridgewater’s Stock Picks with Huge Upside Potential